BridgeBio cardiac data shows BBP-418 benefit in muscle disease trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: BBIO) | Delayed: 68.06 +0.32 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.74 | 52 Week High | $ | |||
| Open | $67.48 | 52 Week Low | $ | |||
| Day High | $69.32 | P/E | N/A | |||
| Day Low | $67.07 | EPS | $ | |||
| Volume | 1,028,172 | |||||
